Attend
Read
Watch
Listen
About Us
Work with Us
Events
Contact
Weekly Digest
Job Board
synbiobeta 2021
live
OCTOBER 4 - 6
May 23-25
Oakland Marriott, California
Register Now
Because Being In The Same Room Is Better Than Being On The Same Zoom!
@ the Oakland Marriott City Center, Oakland CA
Back
Contact
What Is Synthetic Biology?
About BWB
Our Staff
Our Writers
Back
Contact
Advertise
Sponsors
Exhibitors
Conflict of Interest
Back
Contact
Job Board
Back
Contact
Current Event
Conferences
Courses
Industry Tours
Attend
Read
Watch
Listen
About Us
Weekly Digest
Site Search
Close
Become a Member
Insider
Free
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
Insider Premium
$3/month
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Preferences
Deny
Accept
Read
OUR LATEST DIGESTS
February 2, 2023
Thomas Middleditch to keynote at SynBioBeta, Colossal to bring back Dodo with $150M raise, VitaDAO’s $4.1m + join our new biopharma newsletter.
Sponsored by:
January 25, 2023
Melonfrost raises $7 million, Inscripta reimagines synbio company, and Ginkgo fires up new enzyme service
Sponsored by:
January 19, 2023
Davos: Biologize Everything + Can BiologIC’s Biocomputer Help Bring Biomanufacturing to Space?
Sponsored by:
See More Digests »
Click Here to Subscribe
to Our Weekly Digest
SYNBIOBETA
SPOTLIGHTS
Lumen Bio
The human immune system is very good at recognizing foreign proteins. While this is critical for protecting against infections, it is sometimes too good: protein therapeutics like monoclonal antibodies are typically much safer than small molecule drugs, but the body often rejects them as foreign. Meet Lumen Bioscience, an antibody engineering company delivering therapeutics to places where our bodies won’t reject them: the GI tract, nasal passages, and skin. Our immune system is accustomed to all the foreign proteins we eat, smell, and touch, so this improves safety. These antibody drugs can be delivered in higher concentrations which improves efficacy against certain diseases. Learn more about Lumen’s promising clinical trial results and how they can produce antibodies at one-hundredth of the cost!
Cambrium
Consider the origins of the products we use in our daily lives; almost everything owes its history to the oil field, the strip mine or the slaughterhouse. Meet Cambrium, a Berlin-based synthetic biology company rethinking the material world by designing sustainable, high-impact proteins and producing them with microbes! By engineering the amino acid sequence in structural proteins, the company creates novel materials with specific properties and functions. Starting with optimized collagen for cosmetics, Cambrium is building a pipeline of highly functional, animal-free, fossil-free ingredients to usher in a new materials future without compromise. Learn more about Cambrium’s first product launch and stay tuned for news of the company’s upcoming collaborations with innovators in skincare and beyond!
SQIM
It’s no secret that animal agriculture is severely damaging our planet. While we transition our diets to sustainable proteins, we also need to reimagine our materials, especially leather. Meet SQIM, a materials company bringing plastic-free "mycelium leather" to market! By leveraging liquid and solid-state fermentation, SQIM is quickly scaling the production of EPHEA, a novel class of superior materials that can be thoroughly customized for use in the fashion industry. EPHEA can be dyed, embossed, finished, and adapted to create animal-free, high-quality products, without harming our planet. Learn more about SQIM, the ongoing scale-up of EPHEA, and their commercially available mycelium-based products for interior design, MOGU! (image: EPHEA)
LUCA
Women’s health has been long overlooked and underserved. Non-prescription supplements often claim to help women’s vaginal microbiome health, but none of them have proven therapeutic value. Meet LUCA Biologics, a biotechnology company developing a new class of microbe-based therapies to treat unmet needs in women's health. The company’s living medicines, which target the vaginal microbiome for urogenital and reproductive health, will go through a full FDA approval process and could finally offer women solutions for antibiotic-resistant UTIs, STIs, bacterial vaginosis and preterm birth. LUCA is also working to support women’s health globally, not only in affluent regions. Learn more about LUCA’s goals of supporting women and keep up with their clinical trial progress!
Molecular Devices & IDT
Collaboration, collaboration, collaboration: that’s the name of the synbio game and that’s why Molecular Devices and IDT are teaming up to make it easier for biotech companies to accelerate their research. For 35 years, IDT has supplied DNA constructs that are critical for research and discovery. Molecular Devices focuses on automated hardware and software for upstream and downstream processing and the robotics needed to screen up to 30,000 DNA clones every day. The companies’ synergy is clear: IDT supplies custom DNA and Molecular Devices provides the tools to efficiently run experiments and analyze the results. Now the companies are taking their synergy a step further. Learn more about IDT and Molecular Devices’ 2022 special offer to accelerate companies operating in the bioeconomy!
Roswell Biotechnologies
Most people wait to feel sick before they go to the doctor. But imagine if you could wake up in the morning, do a quick scan of your health using a semiconductor chip and immediately know your health status before symptoms even start. This kind of technology could democratize healthcare and ensure everyone can access their health information quickly and reliably. Meet Roswell Biotechnologies, a company turning individual molecules into biosensors on a chip. By miniaturizing biosensors, Roswell is able to fully leverage the power of chip technology to create scalable, affordable data snapshots about our health and our environment. Learn more about how Roswell is deploying their technology in drug discovery, biosecurity, crop protection, and much more!
See More Spotlights »
INDUSTRY NEWS
Filter by Category
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
Premiere Synthetic Biology Event on Track for Record Attendance - 2023
February 2, 2023
SNIPR Biome further strengthens CRISPR/Cas IP portfolio with patent grant
December 23, 2022
Ganymede Bio, the Cloud Provider Purpose-Built for the Life Sciences and Manufacturing Industries, Raises $12.75 Million in Series A Funding
December 23, 2022
EnginZyme Raises €21 Million in Series B to Accelerate the Commercialisation of Its Cell-Free Biomanufacturing Technology
December 19, 2022
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
December 19, 2022
CATALOG Achieves Historic DNA Computing Milestone
December 13, 2022
Portuguese biotech company SilicoLife secures Series A investment of up to €9.8 million to accelerate the biological production of ingredients.
December 13, 2022
Gamida Cell Announces Closing of $25 Million Financing With Highbridge
December 12, 2022
GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification
December 9, 2022
Ginkgo Bioworks Launches Ginkgo Enzyme Services, Enabling Applications across Pharmaceuticals and Diagnostics, Food and Agriculture, and Beyond
December 9, 2022
Pixelgen Technologies Launches to Advance Single-Cell Spatial Proteomics
December 7, 2022
LanzaTech and Sumitomo Riko Partner to Create Substitute for Natural Rubber Production
November 29, 2022
Touchlight receives grant to advance rapid, scalable and thermostable doggybone DNA vaccine platform
November 29, 2022
BigHat Biosciences Announces Research Collaboration with Merck
November 29, 2022
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics
November 29, 2022
Strand Therapeutics Announces Series A1 Bringing Total Round to US$97 Million
November 29, 2022
Elemental Machines raises $41 million to fuel growth
November 13, 2022
Prince William Unveils LanzaTech as a Finalist for the Second Annual Earthshot Prize Awards
November 7, 2022
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer
October 28, 2022
Provectus Algae Strengthens R&D Team, Reinforcing Commitment to Delivering Sustainable Synbio Solutions
October 28, 2022
Ginkgo Bioworks and the Ministry of Investment of Saudi Arabia Announce Plans to Develop Biosecurity and Biotechnology Capabilities for Global Public Health
October 25, 2022
Previous
Next
2 / 163